Young Shin Kim1, Myeong Yeon Yi1, Young Jae Hong2, Ka Hee Park3. 1. Department of Ophthalmology, Soonchunhyang University College of Medicine, Soonchunhyang University Seoul Hospital, Seoul, Korea. 2. The Glaucoma and Cataract Center of Nune Eye Hospital, Seoul, Korea. 3. Department of Ophthalmology, Soonchunhyang University College of Medicine, Soonchunhyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon, 14584, Korea. ophkh@schmc.ac.kr.
Abstract
PURPOSE: To investigate the visual symptoms and to determine the impact of visual symptoms on vision-related quality of life (QoL) in patients with early to moderate glaucoma. METHODS: A retrospective, hospital-based, cross-sectional study was conducted from July 1 to August 31, 2014, at a university referral center. A total of 176 patients with early to moderate glaucoma underwent a comprehensive ocular examination, including Humphrey visual field testing. The patients were divided into six groups based on visual symptoms that could be verified by forced-choice questions. Vision-related QoL was assessed by the Korean version of the National Eye Institute Visual Function Questionnaire 25 (K-NEI-VFQ-25). We compared the mean deviation (MD) and questionnaire scores among the groups. RESULTS: Of 352 eyes, 107 (30.4%) were symptomatic. The most common visual symptoms were partial blurring (15.91%), followed by a missing part (7.67%) and a black part (5.97%) of the image. The symptomatic groups (blurred part and missing part) had a significantly worse MD than the asymptomatic group. The symptomatic groups tended to have more visual field defects than the asymptomatic group. The overall NEI-VFQ-25 score in the symptomatic group (black part) was significantly lower than that in the asymptomatic group. Similar effects were observed for other subscale scores, including social functioning, mental health, role difficulties, dependency, and peripheral vision. CONCLUSIONS: Vision-related QoL may be severely compromised in glaucoma patients with visual symptoms. Patients with visual disorders should be evaluated for glaucoma and QoL.
PURPOSE: To investigate the visual symptoms and to determine the impact of visual symptoms on vision-related quality of life (QoL) in patients with early to moderate glaucoma. METHODS: A retrospective, hospital-based, cross-sectional study was conducted from July 1 to August 31, 2014, at a university referral center. A total of 176 patients with early to moderate glaucoma underwent a comprehensive ocular examination, including Humphrey visual field testing. The patients were divided into six groups based on visual symptoms that could be verified by forced-choice questions. Vision-related QoL was assessed by the Korean version of the National Eye Institute Visual Function Questionnaire 25 (K-NEI-VFQ-25). We compared the mean deviation (MD) and questionnaire scores among the groups. RESULTS: Of 352 eyes, 107 (30.4%) were symptomatic. The most common visual symptoms were partial blurring (15.91%), followed by a missing part (7.67%) and a black part (5.97%) of the image. The symptomatic groups (blurred part and missing part) had a significantly worse MD than the asymptomatic group. The symptomatic groups tended to have more visual field defects than the asymptomatic group. The overall NEI-VFQ-25 score in the symptomatic group (black part) was significantly lower than that in the asymptomatic group. Similar effects were observed for other subscale scores, including social functioning, mental health, role difficulties, dependency, and peripheral vision. CONCLUSIONS: Vision-related QoL may be severely compromised in glaucomapatients with visual symptoms. Patients with visual disorders should be evaluated for glaucoma and QoL.
Entities:
Keywords:
Glaucoma; Quality of life; Visual field; Visual symptoms
Authors: Ryo Asaoka; David P Crabb; Takehiro Yamashita; Richard A Russell; Ya Xing Wang; David F Garway-Heath Journal: Invest Ophthalmol Vis Sci Date: 2011-09-01 Impact factor: 4.799
Authors: David P Crabb; Nicholas D Smith; Fiona C Glen; Robyn Burton; David F Garway-Heath Journal: Ophthalmology Date: 2013-02-12 Impact factor: 12.079
Authors: Peter A Aspinall; Zoe K Johnson; Augusto Azuara-Blanco; Alicia Montarzino; Roger Brice; Adrian Vickers Journal: Invest Ophthalmol Vis Sci Date: 2008-05 Impact factor: 4.799
Authors: Cindy X Hu; Camila Zangalli; Michael Hsieh; Lalita Gupta; Alice L Williams; Jesse Richman; George L Spaeth Journal: Am J Med Sci Date: 2014-11 Impact factor: 2.378
Authors: Melissa H Y Wong; Eva Fenwick; Ai Tee Aw; Ecosse L Lamoureux; Lay Leng Seah Journal: Transl Vis Sci Technol Date: 2018-10-01 Impact factor: 3.283